Through epidemiologic studies, high levels of IGFBP3 are associated with decreased risk of several common cancers, including PCa [78], breast cancer [79], colorectal cancer [80] and lung cancer [81]. The gene discussed is IGFBP3; the disease is lung carcinoma.